| Outgoing Relation(s) |
| antimitotic (CHEBI:64911) is a pharmacological role (CHEBI:52210) |
| Incoming Relation(s) |
| 2-acetamidofluorene (CHEBI:17356) has role antimitotic (CHEBI:64911) |
| 2-methoxy-17β-estradiol (CHEBI:28955) has role antimitotic (CHEBI:64911) |
| 3-hydroxydecanoic acid (CHEBI:132983) has role antimitotic (CHEBI:64911) |
| aphidicolin (CHEBI:2766) has role antimitotic (CHEBI:64911) |
| cafenstrole (CHEBI:81787) has role antimitotic (CHEBI:64911) |
| ceratamine A (CHEBI:65608) has role antimitotic (CHEBI:64911) |
| ceratamine B (CHEBI:65609) has role antimitotic (CHEBI:64911) |
| chamaejasmenin A (CHEBI:65614) has role antimitotic (CHEBI:64911) |
| chamaejasmenin D (CHEBI:65615) has role antimitotic (CHEBI:64911) |
| dimethenamid (CHEBI:81789) has role antimitotic (CHEBI:64911) |
| dimethenamid-P (CHEBI:83640) has role antimitotic (CHEBI:64911) |
| GSK-923295 (CHEBI:234356) has role antimitotic (CHEBI:64911) |
| hydroxyurea (CHEBI:44423) has role antimitotic (CHEBI:64911) |
| isochamaejasmenin B (CHEBI:66091) has role antimitotic (CHEBI:64911) |
| laulimalide (CHEBI:69134) has role antimitotic (CHEBI:64911) |
| LLP-3 (CHEBI:78766) has role antimitotic (CHEBI:64911) |
| maytansine (CHEBI:6701) has role antimitotic (CHEBI:64911) |
| mefenacet (CHEBI:34830) has role antimitotic (CHEBI:64911) |
| monastrol (CHEBI:75382) has role antimitotic (CHEBI:64911) |
| nocodazole (CHEBI:34892) has role antimitotic (CHEBI:64911) |
| oryzalin (CHEBI:73163) has role antimitotic (CHEBI:64911) |
| pederin (CHEBI:78591) has role antimitotic (CHEBI:64911) |
| peloruside A (CHEBI:77692) has role antimitotic (CHEBI:64911) |
| podophyllotoxin (CHEBI:50305) has role antimitotic (CHEBI:64911) |
| rhizoxin (CHEBI:72590) has role antimitotic (CHEBI:64911) |
| zoxamide (CHEBI:82048) has role antimitotic (CHEBI:64911) |
| microtubule-destabilising agent (CHEBI:61951) is a antimitotic (CHEBI:64911) |
